Transaction · 0001231589-26-000006

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 1177.000000 shares for an estimated $568114.48. Reported holdings after the transaction were 41277.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeMar 05
Trade dateMar 05, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$485.06
Pre-filing
1mo ago -1.4%1w ago +3.8%1d ago +1.1%
Returns since
7d +9.8%30d +16.4%90d +13.3%180d +6.8%1y +6.8%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-03-05Filed 183 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231589-26-000006
Common Stock
Transaction date
Mar 05, 2026
Filed Mar 05, 2026, 12:00 AM · 0d delay
Shares
1.17k sh
$48.2k per share
Estimated value
-$56.8M
Computed from shares × price
Holdings after
41.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F10

    This transaction was executed in multiple trades at prices ranging from $486.41 to $486.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  3. F11

    This transaction was executed in multiple trades at prices ranging from $487.475 to $487.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  4. F2

    Includes 63 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan.

  5. F3

    This transaction was executed in multiple trades at prices ranging from $478.82 to $479.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F4

    This transaction was executed in multiple trades at prices ranging from $479.82 to $480.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  7. F5

    This transaction was executed in multiple trades at prices ranging from $481.02 to $481.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  8. F6

    This transaction was executed in multiple trades at prices ranging from $482.025 to $482.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  9. F7

    This transaction was executed in multiple trades at prices ranging from $483.07 to $484.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  10. F8

    This transaction was executed in multiple trades at prices ranging from $484.07 to $484.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  11. F9

    This transaction was executed in multiple trades at prices ranging from $485.10 to $485.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001231589-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR